Affiliation:
1. State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning 530021, China
Abstract
Nanodynamic therapy (NDT) exerts its anti-tumor effect by activating nanosensitizers to generate large amounts of reactive oxygen species (ROS) in tumor cells. NDT enhances tumor-specific targeting and selectivity by leveraging the tumor microenvironment (TME) and mechanisms that boost anti-tumor immune responses. It also minimizes damage to surrounding healthy tissues and enhances cytotoxicity in tumor cells, showing promise in cancer treatment, with significant potential. This review covers the research progress in five major nanodynamic therapies: photodynamic therapy (PDT), electrodynamic therapy (EDT), sonodynamic therapy (SDT), radiodynamic therapy (RDT), and chemodynamic therapy (CDT), emphasizing the significant role of advanced nanotechnology in the development of NDT for anti-tumor purposes. The mechanisms, effects, and challenges faced by these NDTs are discussed, along with their respective solutions for enhancing anti-tumor efficacy, such as pH response, oxygen delivery, and combined immunotherapy. Finally, this review briefly addresses challenges in the clinical translation of NDT.
Funder
Guangxi Science and Technology Major Program
National Nature Science Foundation of China
Scientific and Technological Innovation Major Base of Guangxi
Reference129 articles.
1. The status and challenges of HPV vaccine programme in China: An exploration of the related policy obstacles;Wang;BMJ Glob. Health,2023
2. Nanoscale biomaterials for terahertz imaging: A non-invasive approach for early cancer detection;Sadeghi;Transl. Oncol.,2023
3. 705 Anti-tumor activity of CB-668, a potent, selective and orally bioavailable small-molecule inhibitor of the immuno-suppressive enzyme Interleukin 4 (IL-4)-Induced Gene 1 (IL4I1);MacKinnon;J. Immunother. Cancer,2020
4. An overview of “Chronic viral infection and cancer, openings for vaccines” virtual symposium of the TechVac Network—December 16–17, 2021;Isaguliants;Infect. Agent Cancer,2022
5. Takahashi, H., Yoshimatsu, G., and Faustman, D.L. (2022). The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy. Cells, 11.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献